Abnormal anandamide metabolism in celiac disease. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/22209002
The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention. (abst – 2012) http/www.sciencedirect.com/science/article/pii/S1043661812000540
Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease. (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062078
The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention. (abst – 2012) http/www.sciencedirect.com/science/article/pii/S1043661812000540
Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease. (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062078